Johnson & Johnson
NYSE:JNJ · New York Stock Exchange
-$4.59 today
Vol 18.74M · Avg 7.71M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+54.70%
Period High
$247.14
Period Low
$147.63
Latest
$228.39
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector

AbbVie Inc.
NYSE:ABBV
$382.93B

UnitedHealth Group Incorporated
NYSE:UNH
$366.17B

Merck & Co., Inc.
NYSE:MRK
$282.20B

Novartis AG
NYSE:NVS
$281.84B

AstraZeneca PLC
NYSE:AZN
$271.37B

Novo Nordisk A/S
NYSE:NVO
$191.46B

Amgen Inc.
NASDAQ:AMGN
$180.95B

Gilead Sciences, Inc.
NASDAQ:GILD
$152.72B

Pfizer Inc.
NYSE:PFE
$143.97B

Sanofi
NASDAQ:SNY
$101.57B
What is the latest JNJ filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does JNJ have?
Intrinsic Alpha currently shows 20 recent filings for JNJ.
Explore More
Continue the stock analysis
Jump to another research area for this company.